Literature DB >> 8739917

Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men.

K F Eriksson1, F Lindgärde.   

Abstract

In a prospective population-based study of middle-aged Caucasian men, performed in Malmö, Sweden, specifically designed to evaluate physical fitness, early and late insulin response as predictors of non-insulin-dependent diabetes mellitus (NIDDM), 4,637 non-diabetic men underwent oral glucose tolerance tests at the ages of 48 and 54 years. At the baseline examination, physical fitness was measured in terms of lung vital capacity and oxygen uptake during ergometry; early insulin response in terms of the 40-min insulin increment during an oral glucose tolerance test (a correlate of acute insulin response to an intravenous glucose tolerance test), and late insulin response were measured in terms of the 2-h insulin value during the oral glucose tolerance test (a correlate of glucose disposal during euglycaemic clamp testing). Of the subjects studied 116 developed NIDDM (0.4% annually), and when compared with non-diabetic men at baseline, they were found to have an 11% higher mean body mass index (p < 0.001), a higher frequency of family history of diabetes (31 vs 18%, p < 0.001), 16% lower mean physical activity index (p < 0.05), 16% lower mean estimated maximal oxygen uptake (p < 0.001), 10% lower mean vital capacity (p < 0.001), 26% lower 40-min to total insulin response ratio (p < 0.001), and a 2.7 times higher mean 2-h insulin value during an oral glucose tolerance test (p < 0.001). Regression analysis (using Cox's proportional hazards model) showed both low vital capacity, and impaired early insulin response but late hyperinsulinaemia to be independent predictors of NIDDM, in addition to body mass index and fasting blood glucose level (p = 0.05-0.0001). Among subjects with impaired glucose tolerance at baseline (44 of 278 developed NIDDM), fasting glucose level alone predicted diabetes in this model. The findings suggest that in this age group in a Caucasian population, not only does insulin resistance precede glucose intolerance and NIDDM, but also loss of early insulin response indicating impaired beta-cell function to be an early feature of the process culminating in diabetes. As both physical fitness [which correlates inversely with late insulin response (r= -0.42, p < 0.0001)], and the level of physical activity were shown to correlate with diabetes development in this large series, measures to correct these adverse features should be included in future strategies for preventing NIDDM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739917     DOI: 10.1007/bf00403304

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

1.  Predicting type II diabetes in persons at risk.

Authors:  K Osei
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

2.  Physical training and glucose tolerance in middle-aged men with chemical diabetes.

Authors:  B Saltin; F Lindgärde; M Houston; R Hörlin; E Nygaard; P Gad
Journal:  Diabetes       Date:  1979-01       Impact factor: 9.461

Review 3.  Aspects of the pathogenesis of type 2 diabetes.

Authors:  S Efendić; R Luft; A Wajngot
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

4.  The importance of diabetes heredity in lean subjects on insulin secretion, blood lipids and oxygen uptake in the pathogenesis of glucose intolerance.

Authors:  K Berntorp; K F Eriksson; F Lindgärde
Journal:  Diabetes Res       Date:  1986-06

5.  Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala.

Authors:  E T Skarfors; K I Selinus; H O Lithell
Journal:  BMJ       Date:  1991-09-28

6.  Early and late insulin response as predictors of NIDDM in Pima Indians with impaired glucose tolerance.

Authors:  D K Nagi; W C Knowler; M A Charles; Q Z Liu; R L Hanson; D R McCance; D J Pettitt; P H Bennett
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

7.  Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study.

Authors:  K F Eriksson; F Lindgärde
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

8.  Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects.

Authors:  P Arner; T Pollare; H Lithell
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

9.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

Authors:  S Lillioja; D M Mott; M Spraul; R Ferraro; J E Foley; E Ravussin; W C Knowler; P H Bennett; C Bogardus
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study.

Authors:  P Lange; S Groth; J Kastrup; J Mortensen; M Appleyard; J Nyboe; G Jensen; P Schnohr
Journal:  Eur Respir J       Date:  1989-01       Impact factor: 16.671

View more
  23 in total

1.  Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.

Authors:  M Lehto; T Tuomi; M M Mahtani; E Widén; C Forsblom; L Sarelin; M Gullström; B Isomaa; M Lehtovirta; A Hyrkkö; T Kanninen; M Orho; S Manley; R C Turner; T Brettin; A Kirby; J Thomas; G Duyk; E Lander; M R Taskinen; L Groop
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Decreased physical fitness in borderline glucose tolerance men.

Authors:  Y Higaki; N Shono; M Nishizumi
Journal:  Environ Health Prev Med       Date:  1998-01       Impact factor: 3.674

3.  A single session of resistance exercise enhances insulin sensitivity for at least 24 h in healthy men.

Authors:  René Koopman; Ralph J F Manders; Antoine H G Zorenc; Gabby B J Hul; Harm Kuipers; Hans A Keizer; Luc J C van Loon
Journal:  Eur J Appl Physiol       Date:  2005-03-11       Impact factor: 3.078

Review 4.  Exercise in the management of non-insulin-dependent diabetes mellitus.

Authors:  H Wallberg-Henriksson; J Rincon; J R Zierath
Journal:  Sports Med       Date:  1998-01       Impact factor: 11.136

5.  Oxygen uptake of overweight and obese children at different stages of a progressive treadmill test: Consumo de oxígeno de niños y niñas con sobrepeso y obesos en los diferentes estadios de una prueba progresiva en un tapiz rodante.

Authors:  Agustín Meléndez-Ortega; Catherine Lucy Davis; Paule Barbeau; Colleen Ann Boyle
Journal:  Rev Int Cienc Deporte       Date:  2010-01-01

6.  Physical Fitness Among Swedish Military Conscripts and Long-Term Risk for Type 2 Diabetes Mellitus: A Cohort Study.

Authors:  Casey Crump; Jan Sundquist; Marilyn A Winkleby; Weiva Sieh; Kristina Sundquist
Journal:  Ann Intern Med       Date:  2016-03-08       Impact factor: 25.391

7.  Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content.

Authors:  Sven Haufe; Stefan Engeli; Petra Budziarek; Wolfgang Utz; Jeanette Schulz-Menger; Mario Hermsdorf; Susanne Wiesner; Christoph Otto; Verena Haas; Armin de Greiff; Friedrich C Luft; Michael Boschmann; Jens Jordan
Journal:  Diabetes       Date:  2010-03-31       Impact factor: 9.461

8.  The association of intensity and overall level of physical activity energy expenditure with a marker of insulin resistance.

Authors:  F K Assah; S Brage; U Ekelund; N J Wareham
Journal:  Diabetologia       Date:  2008-05-17       Impact factor: 10.122

Review 9.  Epigenetics: a molecular link between environmental factors and type 2 diabetes.

Authors:  Charlotte Ling; Leif Groop
Journal:  Diabetes       Date:  2009-12       Impact factor: 9.461

10.  Low cardiorespiratory fitness in people at risk for type 2 diabetes: early marker for insulin resistance.

Authors:  Silmara Ao Leite; Arlene M Monk; Paul A Upham; Richard M Bergenstal
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.